GovChime
AWARDDELIVERY ORDEROther than small business

Delivery order 75F40119F19001HARVARD PILGRIM HEALTH CARE INC

Overview

Award facts

Net obligations
$110.69M
$110,687,596of $110.69M potential value
Outlays (paid to date)
$82.99M
$82.99M paid of $110.69M obligated$82,994,874
Period of performance
Sep 28, 2019 to Dec 31, 2024
Ended
Modifications
18
Latest action Aug 20, 2026
Contract type
Delivery order
PIID 75F40119F19001

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

SENTINEL INITIATIVE-OPERATIONS CENTER

Dates and value

Award date
Signed on Sep 28, 2019
Current value
$110,687,596Base and exercised options
Potential value (if all options are exercised)
$110,687,596
Parent contract vehicle
75F40119D10037 (IDC, single award) — 13 orders recorded under it

Obligations by fiscal year of action

  • FY2026: -$3,324,437 (de-obligation)
  • FY2023: $16,981,646
  • FY2022: $21,147,591
  • FY2021: $33,938,312
  • FY2020: $25,694,484
  • FY2019: $16,250,000

Total across 6 fiscal years: $110,687,596

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Aug 20, 2026. View on USAspending · Recipient on SAM.gov

Recipient

LocationWELLESLEY, MA
UEINZVVQ8GNVX65
CAGE code4ADV0
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate tax exempt

Business types and certifications

Nonprofit organizationTax-exempt corporation

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. Food And Drug Administration
  3. FDA OFFICE OF ACQ GRANT SVCS
Funded from
Cures activities; Foods; Human drugs; Devices and radiological health; Fda other activities (fda headquaters); Animal drugs and feed; Biologics; Coronavirus emergency funding supplemental; Fda user fees (non general fund); Fda reimbursable program (federal sources)Program activities075-0600, 075-5629Federal accounts (agency financial reports)

Place of performance

Place of performance
Wellesley Hills, Norfolk County, Massachusetts 02481-3609
Congressional district (place of performance)
MA-04As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Firm fixed priceJ

Solicitation and notices

Solicitation ID
FDA19RFP1209951(as reported)
Solicitation date
Mar 23, 2019

Contract details

Subcontracting plan
Individual subcontract planF
Certified cost or pricing data
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
Yes - service where PBA is used.Y

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Sep 28, 2019Base obligation at award: $16,250,000
Latest action
Aug 20, 2026 — CloseoutModification P00018; obligation change -$3,324,437; administrative: no change in scope or value
Latest substantive action
Feb 2, 2023 — Option exercisedModification P00016; obligation change +$16,981,646
Latest funding action
Jun 13, 2022 — Funding onlyModification P00014; obligation change +$21,147,591; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Supplemental agreement (within scope)6
  • Other administrative action5
  • Funding only4
  • Option exercised2
  • Closeout1
19 actions recorded, Sep 28, 2019 to Aug 20, 2026; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$3,324,437
Latest action: change in base and all options
-$3,324,437

Socio-economic and policy

Inherently governmental functions
Critical functionsCT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Delivery orderC
Parent vehicle type
IDCB
Parent vehicle: multiple or single award
Single awardS
Parent vehicle agency
Food And Drug Administration7524
Awarding agency code
7500
Awarding sub-tier code
7524
Contracting office code
75F401
Transactions recorded under this award key
19

Funding

Funding agency code
7500
Funding sub-tier code
7524
Funding office code
75F401
Treasury accounts
  • 075-2019/2019-0600-000
  • 075-2020/2020-0600-000
  • 075-2021/2021-0600-000
  • 075-2022/2022-0600-000
  • 075-2023/2023-0600-000
  • 075-X-0600-000
Show all 7 accounts
  • 075-X-5629-000
Object classes
  • 25.1: Advisory and assistance services
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • N: Emergency P.L. 116-136
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
  • V: Non-emergency P.L. 117-2
COVID-19 supplemental obligations
$8,610,658
COVID-19 supplemental outlays
$8,087,962